LARS Score post CHT-RT

TIMING TO MINIMALLY INVASIVE SURGERY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR RECTAL CANCER: A MULTICENTER RANDOMIZED CONTROLLED TRIAL

[crowdsignal type=”iframe” survey=”B3A77C4019D7B6CC” height=”auto” domain=”igormonsellato” id=”lars-score-post-cht-rt”]